caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518901552

James NobleMD

Infectious DiseaseConcord, NHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where James Noble's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 33 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CONCORD HOSPITAL, INC.2022,334
Joshua White
Infectious Disease · Concord, NH
78221
Joseph Venus
Diagnostic Radiology · Concord, NH
56119
Kevin Rivera Colon
Diagnostic Radiology · Manchester, NH
51111
CHAN, DON4280
Matthew Dimasi
Diagnostic Radiology · Concord, NH
3557
Tad Renvyle
Diagnostic Radiology · Bedford, NH
3175
Jimmy Fune
Hospitalist · Concord, NH
2234
Charles Wicks
Cardiology · Concord, NH
2235
Jennifer Stone
Physician Assistant · Concord, NH
20447
Ashley Fox
Emergency Medicine · Littleton, NH
2046
Melkon Hacobian
Cardiology · Santa Monica, CA
1935
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
256
Unique beneficiaries
—
Total services
444
Distinct HCPCS
3
Medicare payment
$36K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 29 Infectious Disease providers in NH — above median (cohort median 338).
PRESCRIBING · PART D · 2024
Total Rx claims
57
Beneficiaries
—
Total drug cost
$222K
Distinct drugs
3
Brand share
100.0%
Top prescribed drugs
Abacavir/Dolutegravir/Lamivudi29 claims
Bictegrav/Emtricit/Tenofov Ala14 claims
Efavirenz/Emtricit/Tenofovr Df14 claims
QUALITY · MIPS · 2024
Final MIPS score
89.0
Quality
73.2
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.59%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.